Search
Dr Kai-Keen Shiu

Dr Kai-Keen Shiu

Medical oncology 04634849

  • Bupa Platinum consultant
  • Fee assured
  • Open Referral network
Overview
Bupa Platinum consultant
Fee assured
Open Referral network

Specialises in

  • Colon
  • Hepatobiliary
  • Lower GI
  • Upper GI

Offers

  • Face-to-face consultations
  • Video and telephone consultations
  • Home chemotherapy

About me

I am a Medical Oncology Consultant for the Gastrointestinal Oncology Service at University College London Hospitals NHS Foundation Trust and Honorary Associate Professor at the UCL Cancer Insitute. I treat oesophageal, stomach, small bowel, colorectal and hepatobiliary cancers, as well as cancers of unknown primary. I am the UCLH Clinical Lead for the Cancer of Unknown Primary Service and the Acute Oncology Service.

My research interests include immunotherapy for GI malignancies and Cancer of Unknown Primary. I am Chief Investigator or Principal Investigator for a number of GI or CUP immuno-oncology Phase 2 and 3 trials, including KEYNOTE 177, NEOPRISM-CRC, LEAP 17, KEYNOTE 859, KEYNOTE 811, KEYNOTE 975, MATTERHORN, VESTIGE and CUPISCO.

I am Chair of the NCRI MUO-CUP Workstream as part of the Living With and Beyond Cancer CSG, and a member of the NCRI Colorectal Advanced and Adjuvant Disease Subgroup. I am the Principal Investigator of the UCL-UCLH GI + CUP Cancer Translational Research Biobank and a collaborator with the GI Oncology and CUP subgroups at the UCL Cancer Institute and Francis Crick Institute. I am a member of ASCO, ESMO and the Association of Cancer Physicans (UK).

Areas of interest

Immunotherapy for gastrointestinal cancers
Cancer of Unknown Primary
Novel clinical trials and trial design
Acute Oncology

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0002

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (>50)

  • 20365

    Follow-up out-patient consultation - remote - (5-50)

  • X0003

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)

  • X0004

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)

  • 20355

    Initial out-patient consultation - remote - (1-5)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.